The Mechanism and Dynamic Regulation of Epithelial to Mesenchymal Transition in Ovarian Cancer

被引:4
|
作者
Prayudi, Pande Kadek Aditya [1 ,2 ]
Winata, I. Gde Sastra [1 ,2 ]
Mahendra, Nyoman Bayu [1 ,2 ]
Budiana, I. Nyoman Gede [1 ,2 ]
Saspriyana, Kade Yudi [1 ,2 ]
Suwiyoga, Ketut [1 ,2 ]
机构
[1] Prof Dr I GNG Ngoerah Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Denpasar 80113, Bali, Indonesia
[2] Udayana Univ, Fac Med, Denpasar 80113, Bali, Indonesia
关键词
ovarian cancer; epithelial-to-mesenchymal transition; cellular reprogramming; PROMOTES VASCULOGENIC MIMICRY; HEDGEHOG SIGNALING PATHWAY; E-CADHERIN; CELL-MIGRATION; STEM-CELLS; TRANSCRIPTION FACTORS; CISPLATIN-RESISTANCE; POOR SURVIVAL; LNCRNA-ATB; EMT;
D O I
10.31083/j.ceog5012272
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To understand the basic mechanism and dynamic regulation that underlies the epithelial-to-mesenchymal transition (EMT) in ovarian cancer (OC) cells. Mechanism: A literature review using evidences from several data bases (i.e., PubMed, EMBASE, Web of Science, Medline, Cochrane, Science Direct, and Google Scholar) were conducted to describe the basic mechanism and dynamic regulation of EMT in OC cells. Finding in Brief: EMT is a complex epigenetic reprogramming orchestrated by specific transcription factors (TFs) and multiple upstream activators and regulators, such as transforming growth factor-0 (TGF-0), Wnt, Hedgehog, and Hippo signaling pathways. The net result of this cellular reprogramming is the acquisition of mesenchymal phenotypes with increased invasive and metastatic potential, stemness properties and chemoresistance. Recent studies have demonstrated that EMT activation is the result of dynamic and reciprocal interplay between OC cells and their tumor microenvironment (TME). Cellular or non-cellular component of TME, external factors related to TME such as hypoxia, oxidative stress, mechanical forces, as well as exposure to chemotherapy, all play significant role to EMT induction. Current understanding behind the mechanism of EMT induction in cancer cells have proposed the idea that EMT is not merely a binary process involving a complete conversion from epithelial to mesenchymal state, but rather a dynamic process that encompasses a range of hybrid states, a phenotype that has been referred to as "partial EMT". Cells with partial EMT have been known to be more apoptosis-resistant and have more tumor-initiating potential as compared to those with complete EMT. Conclusions: Understanding the complex regulatory network that underlies EMT in OC cells is crucial in order to gain insight in developing novel and effective treatment strategies for OC.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Mechanism and regulation of epithelial-mesenchymal transition in cancer
    Reed, Irene K. Guttilla
    CELL HEALTH AND CYTOSKELETON, 2015, 7 : 155 - 165
  • [2] Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
    Deng, Junli
    Wang, Li
    Chen, Hongmin
    Hao, Jingli
    Ni, Jie
    Chang, Lei
    Duan, Wei
    Graham, Peter
    Li, Yong
    ONCOTARGET, 2016, 7 (34) : 55771 - 55788
  • [3] Overexpressed FOXC2 in ovarian cancer enhances the epithelial-to-mesenchymal transition and invasion of ovarian cancer cells
    Liu, Bo
    Han, Shu-Mei
    Tang, Xiao-Yong
    Han, Li
    Li, Chang-Zhong
    ONCOLOGY REPORTS, 2014, 31 (06) : 2545 - 2554
  • [4] Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds
    Ang, Hui Li
    Mohan, Chakrabhavi Dhananjaya
    Shanmugam, Muthu K.
    Leong, Hin Chong
    Makvandi, Pooyan
    Rangappa, Kanchugarakoppal S.
    Bishyaee, Anupam
    Kumar, Alan Prem
    Sethi, Gautam
    MEDICINAL RESEARCH REVIEWS, 2023, 43 (04) : 1141 - 1200
  • [5] Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway
    Hu, Chen
    Dong, Taotao
    Li, Rui
    Lu, Jingjing
    Wei, Xuan
    Liu, Peishu
    ONCOLOGY REPORTS, 2016, 35 (04) : 2027 - 2034
  • [6] Relationship between ovarian cancer stem cells, epithelial mesenchymal transition and tumour recurrence
    Padilla, Monica Angelica Amaya
    Binju, Mudra
    Wan, Graeme
    Rahmanto, Yohan Suryo
    Kaur, Pritinder
    Yu, Yu
    CANCER DRUG RESISTANCE, 2019, 2 (04) : 1127 - 1135
  • [7] NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer
    Qin, Shan
    Li, Yanfang
    Cao, Xuexia
    Du, Jiexian
    Huang, Xianghua
    BIOSCIENCE REPORTS, 2017, 37
  • [8] The Epithelial-Mesenchymal Transition and the Estrogen-Signaling in Ovarian Cancer
    Gallo, D.
    Ferlini, C.
    Scambia, G.
    CURRENT DRUG TARGETS, 2010, 11 (04) : 474 - 481
  • [9] Epithelial-mesenchymal transition in ovarian cancer
    Vergara, Daniele
    Merlot, Benjamin
    Lucot, Jean-Philippe
    Collinet, Pierre
    Vinatier, Denis
    Fournier, Isabelle
    Salzet, Michel
    CANCER LETTERS, 2010, 291 (01) : 59 - 66
  • [10] Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
    Chen, Chen
    Huang, Shuang
    Chen, Chang-Liang
    Su, Sing-Bing
    Fang, Dong-Dong
    MOLECULES, 2019, 24 (20):